Raltitrexed as monochemotherapy induces a statistically significant increase in platelet count.
Giuseppe
G
Tonini
Daniele
D
Santini
Bruno
B
Vincenzi
Giordano
G
Dicuonzo
Alfredo
A
Salerno
Erica
E
Finolezzi
Giuseppe
G
Avvisati
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects*; D015179:Colorectal Neoplasms / Q000097:blood / Q000188:drug therapy*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count; D011799:Quinazolines / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D006454:Hemoglobins; D011799:Quinazolines; D013876:Thiophenes; C068874:raltitrexed